Alpha 2.0
Login Register
» Articles » PMID: 15618590

High Dose Intravenous AAT and Plasma Neutrophil Derived Fibrinogen Fragments

Overview
Journal Thorax
Date 2004 Dec 25
PMID 15618590
Citations 5
Authors
J Stolk
W Nieuwenhuizen
J K Stoller
L Aboussouan
Affiliations
Soon will be listed here.
Citing Articles

Assessing the efficacy of Alpha-Proteinase inhibitor (human) augmentation therapy for Alpha-Antitrypsin deficiency - Related emphysema: Challenges and opportunities.

Pierce L Heliyon. 2024; 10(11):e31183.

PMID: 38912501 PMC: 11190464. DOI: 10.1016/j.heliyon.2024.e31183.

Serum Proteins Associated with Emphysema Progression in Severe Alpha-1 Antitrypsin Deficiency.

Beiko T, Janech M, Alekseyenko A, Atkinson C, Coxson H, Barth J Chronic Obstr Pulm Dis. 2017; 4(3):204-216.

PMID: 28848932 PMC: 5556912. DOI: 10.15326/jcopdf.4.3.2016.0180.

Exploration of α1-antitrypsin treatment protocol for islet transplantation: dosing plan and route of administration.

Baranovski B, Ozeri E, Shahaf G, Ochayon D, Schuster R, Bahar N J Pharmacol Exp Ther. 2016; 359(3):482-490.

PMID: 27821710 PMC: 5118642. DOI: 10.1124/jpet.116.236067.

Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach.

Stockley R, Miravitlles M, Vogelmeier C Orphanet J Rare Dis. 2013; 8:149.

PMID: 24063809 PMC: 3852071. DOI: 10.1186/1750-1172-8-149.

Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency.

Stolk J, Veldhuisen B, Annovazzi L, Zanone C, Versteeg E, Van Kuppevelt T Respir Res. 2005; 6:47.

PMID: 15927063 PMC: 1159172. DOI: 10.1186/1465-9921-6-47.